These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
116 related articles for article (PubMed ID: 9772447)
1. [The reversion of multidrug resistance in tumour cell line MCF-7/Adr by ribozyme]. Yuan Y; Zhang J; Zhou D Zhonghua Yi Xue Za Zhi; 1997 Jul; 77(7):494-6. PubMed ID: 9772447 [TBL] [Abstract][Full Text] [Related]
2. Reversion of multidrug resistance in the P-glycoprotein positive breast cancer cell line (MCF-7/ADR) by introduction of hammerhead ribozyme. Yuan Y; Zhang J; Scanlon KJ; Lu Z; Qi G Chin Med Sci J; 1998 Mar; 13(1):24-8. PubMed ID: 11717919 [TBL] [Abstract][Full Text] [Related]
3. [Reversing multidrug resistance in breast cancer cell line MCF-7/ADR by small interfering RNA]. Li CB; Zhang F; Shi YR; Wei XY; Yang Y; Niu RF Ai Zheng; 2004 Dec; 23(12):1605-10. PubMed ID: 15601546 [TBL] [Abstract][Full Text] [Related]
4. Reversion of multidrug resistance in the P-glycoprotein-positive human pancreatic cell line (EPP85-181RDB) by introduction of a hammerhead ribozyme. Holm PS; Scanlon KJ; Dietel M Br J Cancer; 1994 Aug; 70(2):239-43. PubMed ID: 7914421 [TBL] [Abstract][Full Text] [Related]
5. [Reversion of multidrug resistance in vitro of lung adenocarcinoma by mdr1 ribozyme]. Chen L; Liu Y Zhonghua Zhong Liu Za Zhi; 2000 May; 22(3):189-91. PubMed ID: 11778227 [TBL] [Abstract][Full Text] [Related]
6. Down-regulation of c-fos by shRNA sensitizes adriamycin-resistant MCF-7/ADR cells to chemotherapeutic agents via P-glycoprotein inhibition and apoptosis augmentation. Shi R; Peng H; Yuan X; Zhang X; Zhang Y; Fan D; Liu X; Xiong D J Cell Biochem; 2013 Aug; 114(8):1890-900. PubMed ID: 23494858 [TBL] [Abstract][Full Text] [Related]
7. Overcoming multi-drug resistance by anti-MDR1 ribozyme. Wang H; Chen XP; Qiu FZ World J Gastroenterol; 2003 Jul; 9(7):1444-9. PubMed ID: 12854138 [TBL] [Abstract][Full Text] [Related]
8. Systematic expression analysis of genes related to multidrug-resistance in isogenic docetaxel- and adriamycin-resistant breast cancer cell lines. Li WJ; Zhong SL; Wu YJ; Xu WD; Xu JJ; Tang JH; Zhao JH Mol Biol Rep; 2013 Nov; 40(11):6143-50. PubMed ID: 24078162 [TBL] [Abstract][Full Text] [Related]
9. Modulation of multidrug resistance gene expression in human breast cancer cells by (-)-gossypol-enriched cottonseed oil. Ye W; Chang HL; Wang LS; Huang YW; Shu S; Dowd MK; Wan PJ; Sugimoto Y; Lin YC Anticancer Res; 2007; 27(1A):107-16. PubMed ID: 17352222 [TBL] [Abstract][Full Text] [Related]
10. [Reversal of multidrug resistance of tumor cells by anti-mdr1 ribozyme]. Gao P; Zhou GY; Zhang QH; Zhou CJ; Zhen JH; Sun YL Zhonghua Bing Li Xue Za Zhi; 2004 Jun; 33(3):251-4. PubMed ID: 15256119 [TBL] [Abstract][Full Text] [Related]
11. [Effects of schisandrin B on reversing multidrug resistance in human breast cancer cells transfected with mdr1 gene]. Li L; Wang T; Xu ZL; Yu Y; Chen W; Chen F Zhonghua Yi Xue Za Zhi; 2005 Jun; 85(23):1633-7. PubMed ID: 16185533 [TBL] [Abstract][Full Text] [Related]
12. Constructing the eukaryotic expression vector to study preliminarily the functions of hammerhead ribozyme targeting base excision repair gene HOGG1. Zhang ZZ; Zhang Q; Wu M Sichuan Da Xue Xue Bao Yi Xue Ban; 2006 Mar; 37(2):165-70. PubMed ID: 16608066 [TBL] [Abstract][Full Text] [Related]
13. The role of c-myc in regulating mdr1 gene expression in tumor cell line KB. He Y; Zhang J; Zhang J; Yuan Y Chin Med J (Engl); 2000 Sep; 113(9):848-51. PubMed ID: 11776085 [TBL] [Abstract][Full Text] [Related]
14. [Reversion of multidrug resistance (MDR) in human glioma cells by RNA interference (RNAi)]. Zhao P; Hu W; Zhang YZ; Sun MZ; He Y Zhonghua Zhong Liu Za Zhi; 2006 Mar; 28(3):183-7. PubMed ID: 16875601 [TBL] [Abstract][Full Text] [Related]
15. Reversal of multidrug resistance by a liposome-MDR1 ribozyme complex. Masuda Y; Kobayashi H; Holland JF; Ohnuma T Cancer Chemother Pharmacol; 1998; 42(1):9-16. PubMed ID: 9619752 [TBL] [Abstract][Full Text] [Related]
16. Restoration of chemosensitivity in cancer cells with MDR phenotype by deoxyribozyme, compared with ribozyme. Xing AY; Shi DB; Liu W; Chen X; Sun YL; Wang X; Zhang JP; Gao P Exp Mol Pathol; 2013 Jun; 94(3):481-5. PubMed ID: 23531420 [TBL] [Abstract][Full Text] [Related]
17. Induction of multidrug resistance in MOLT-4 cells by anticancer agents is closely related to increased expression of functional P-glycoprotein and MDR1 mRNA. Liu ZL; Onda K; Tanaka S; Toma T; Hirano T; Oka K Cancer Chemother Pharmacol; 2002 May; 49(5):391-7. PubMed ID: 11976833 [TBL] [Abstract][Full Text] [Related]
18. Complete reversal by thaliblastine of 490-fold adriamycin resistance in multidrug-resistant (MDR) human breast cancer cells. Evidence that multiple biochemical changes in MDR cells need not correspond to multiple functional determinants for drug resistance. Chen G; Waxman DJ J Pharmacol Exp Ther; 1995 Sep; 274(3):1271-7. PubMed ID: 7562498 [TBL] [Abstract][Full Text] [Related]
19. Reversal of P-glycoprotein-mediated multidrug resistance in vitro by doramectin and nemadectin. Gao A; Wang X; Xiang W; Liang H; Gao J; Yan Y J Pharm Pharmacol; 2010 Mar; 62(3):393-9. PubMed ID: 20487225 [TBL] [Abstract][Full Text] [Related]
20. Reversal of P-glycoprotein-mediated multidrug resistance in vitro by milbemycin compounds in adriamycin-resistant human breast carcinoma (MCF-7/adr) cells. Xiang W; Gao A; Liang H; Li C; Gao J; Wang Q; Shuang B; Zhang J; Yan Y; Wang X Toxicol In Vitro; 2010 Sep; 24(6):1474-81. PubMed ID: 20656007 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]